MoneyWorks4Me

Shamrock Indl. Co - Quaterly Results

25 May 2022 Evaluate
The revenue slipped marginally during the March 2022 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -0.53 millions as compared to Net Loss of Rs. -1.76 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 improved to -0.53% as compared to -1.76% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.09 0.00 0.97 0.09 977.78 0.97 0.09 977.78
PBIDT -0.53 -1.76 -69.89 -2.07 -3.13 -33.87 -2.07 -3.13 -33.87
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.53 -1.76 -69.89 -2.07 -3.13 -33.87 -2.07 -3.13 -33.87
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.53 -1.76 -69.89 -2.07 -3.13 -33.87 -2.07 -3.13 -33.87
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.53 -1.76 -69.89 -2.07 -3.13 -33.87 -2.07 -3.13 -33.87
Equity 54.28 54.28 0.00 54.28 54.28 0.00 54.28 54.28 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..